Systematic mapping of rRNA 2'-O methylation during frog development and involvement of the methyltransferase Fibrillarin in eye and craniofacial development in Xenopus laevis.
Animals
Chromosomal Proteins, Non-Histone
/ genetics
Eye
/ growth & development
Gene Knockdown Techniques
Methylation
Neural Crest
/ growth & development
Neural Plate
/ growth & development
RNA Precursors
/ metabolism
RNA Processing, Post-Transcriptional
RNA, Ribosomal, 18S
/ metabolism
RNA, Ribosomal, 28S
/ metabolism
Xenopus Proteins
/ genetics
Xenopus laevis
/ genetics
Journal
PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
31
12
2020
accepted:
23
12
2021
revised:
28
01
2022
pubmed:
19
1
2022
medline:
19
2
2022
entrez:
18
1
2022
Statut:
epublish
Résumé
Ribosomes are essential nanomachines responsible for protein production. Although ribosomes are present in every living cell, ribosome biogenesis dysfunction diseases, called ribosomopathies, impact particular tissues specifically. Here, we evaluate the importance of the box C/D snoRNA-associated ribosomal RNA methyltransferase fibrillarin (Fbl) in the early embryonic development of Xenopus laevis. We report that in developing embryos, the neural plate, neural crest cells (NCCs), and NCC derivatives are rich in fbl transcripts. Fbl knockdown leads to striking morphological defects affecting the eyes and craniofacial skeleton, due to lack of NCC survival caused by massive p53-dependent apoptosis. Fbl is required for efficient pre-rRNA processing and 18S rRNA production, which explains the early developmental defects. Using RiboMethSeq, we systematically reinvestigated ribosomal RNA 2'-O methylation in X. laevis, confirming all 89 previously mapped sites and identifying 15 novel putative positions in 18S and 28S rRNA. Twenty-three positions, including 10 of the new ones, were validated orthogonally by low dNTP primer extension. Bioinformatic screening of the X. laevis transcriptome revealed candidate box C/D snoRNAs for all methylated positions. Mapping of 2'-O methylation at six developmental stages in individual embryos indicated a trend towards reduced methylation at specific positions during development. We conclude that fibrillarin knockdown in early Xenopus embryos causes reduced production of functional ribosomal subunits, thus impairing NCC formation and migration.
Identifiants
pubmed: 35041640
doi: 10.1371/journal.pgen.1010012
pii: PGENETICS-D-20-01958
pmc: PMC8797249
doi:
Substances chimiques
Chromosomal Proteins, Non-Histone
0
RNA Precursors
0
RNA, Ribosomal, 18S
0
RNA, Ribosomal, 28S
0
Xenopus Proteins
0
fibrillarin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1010012Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Rev Genet. 2018 Jul;19(7):431-452
pubmed: 29725087
J Cell Biol. 2020 Jun 1;219(6):
pubmed: 32330234
Pharmaceuticals (Basel). 2019 Oct 09;12(4):
pubmed: 31600948
Am J Hum Genet. 2019 Oct 3;105(4):869-878
pubmed: 31564433
RNA. 2020 Dec;26(12):1919-1934
pubmed: 32912962
PLoS Genet. 2015 Mar 10;11(3):e1005018
pubmed: 25756904
Cancer Cell. 2013 Sep 9;24(3):318-30
pubmed: 24029231
BMC Dev Biol. 2016 Oct 26;16(1):38
pubmed: 27784267
Development. 2018 Oct 18;145(20):
pubmed: 30337486
Wiley Interdiscip Rev RNA. 2015 Mar-Apr;6(2):225-42
pubmed: 25346433
Science. 2017 Nov 3;358(6363):
pubmed: 29097519
Nucleic Acids Res. 2018 Oct 12;46(18):9289-9298
pubmed: 30202881
Nat Commun. 2016 Jun 06;7:11390
pubmed: 27265389
Cell Rep. 2013 May 30;3(5):1493-502
pubmed: 23707062
Angew Chem Int Ed Engl. 2015 Jan 7;54(2):451-5
pubmed: 25417815
Development. 2015 Oct 1;142(19):3416-28
pubmed: 26443638
EMBO J. 2019 Jul 1;38(13):e100278
pubmed: 31268599
Biochimie. 1995;77(1-2):22-9
pubmed: 7599273
Mol Cell Biol. 2003 Dec;23(23):8519-27
pubmed: 14612397
Rare Dis. 2015 Apr 01;3(1):e1025185
pubmed: 26442198
Mol Cell. 2013 Aug 22;51(4):539-51
pubmed: 23973377
Enzymes. 2017;41:169-213
pubmed: 28601222
Dev Biol. 2004 Jul 15;271(2):439-66
pubmed: 15223346
Science. 2003 Jan 10;299(5604):259-62
pubmed: 12522253
Methods. 2001 Nov;25(3):374-82
pubmed: 11860292
Nat Rev Mol Cell Biol. 2008 Mar;9(3):242-53
pubmed: 18292779
Mol Biol Evol. 2020 Jan 1;37(1):149-166
pubmed: 31553476
EMBO J. 1990 Jul;9(7):2299-308
pubmed: 2357971
Biol Cell. 2011 Oct 1;103(10):483-98
pubmed: 21770895
Mol Cell. 2019 Dec 5;76(5):767-783.e11
pubmed: 31540874
Nucleic Acids Res. 2012 Jan;40(1):391-8
pubmed: 21908402
Trends Biochem Sci. 2010 May;35(5):267-77
pubmed: 20097077
Nucleic Acids Res. 2020 Feb 20;48(3):1013-1028
pubmed: 31350888
Hum Mol Genet. 2008 Oct 15;17(20):3204-11
pubmed: 18653748
Nucleic Acids Res. 2016 Sep 19;44(16):e135
pubmed: 27302133
Methods Enzymol. 1993;225:361-73
pubmed: 8231863
RNA Biol. 2017 Sep 2;14(9):1138-1152
pubmed: 27911188
Sci Rep. 2019 Dec 2;9(1):18130
pubmed: 31792295
Dev Biol. 2013 Jan 1;373(1):39-52
pubmed: 23064029
Nucleic Acids Res. 2003 Jan 1;31(1):439-41
pubmed: 12520045
EMBO Rep. 2020 Jul 3;21(7):e49443
pubmed: 32350990
Wiley Interdiscip Rev RNA. 2012 May-Jun;3(3):397-414
pubmed: 22065625
PLoS Genet. 2016 Jul 22;12(7):e1006187
pubmed: 27448281
Cell. 1989 Dec 1;59(5):893-903
pubmed: 2590945
Nat Struct Mol Biol. 2017 Sep 7;24(9):689-699
pubmed: 28880863
PLoS Genet. 2014 Jan 30;10(1):e1004074
pubmed: 24497835
Development. 2011 Jun;138(11):2369-78
pubmed: 21558383
RNA Biol. 2020 Jan;17(1):150-164
pubmed: 31566069
Nat Struct Mol Biol. 2015 Jan;22(1):11-9
pubmed: 25565028
Trends Genet. 2019 Oct;35(10):754-767
pubmed: 31376929
J Cell Biol. 1998 Sep 7;142(5):1167-80
pubmed: 9732279
Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13403-8
pubmed: 16938878
Development. 1991 Apr;111(4):1045-55
pubmed: 1879349
Nat Struct Biol. 2003 Apr;10(4):256-63
pubmed: 12598892
Nat Struct Mol Biol. 2015 Apr;22(4):342-344
pubmed: 25775268
Nucleic Acids Res. 2019 Sep 5;47(15):7719-7733
pubmed: 31328227
Nucleic Acids Res. 2019 Jul 2;47(W1):W636-W641
pubmed: 30976793
J Mol Biol. 1986 Jun 20;189(4):681-99
pubmed: 3783688
Dev Biol. 1998 Nov 1;203(1):36-48
pubmed: 9806771
Nat Rev Mol Cell Biol. 2019 Feb;20(2):116-131
pubmed: 30467428
Cell. 2011 Apr 29;145(3):383-397
pubmed: 21529712
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):12934-12939
pubmed: 29158377
J Mol Biol. 1999 Mar 12;286(5):1347-63
pubmed: 10064702
Dev Biol. 2008 Oct 15;322(2):355-67
pubmed: 18721802
Dev Biol. 2018 May 1;437(1):1-16
pubmed: 29477341
Nat Med. 2008 Feb;14(2):125-33
pubmed: 18246078
J Biol Chem. 2004 Oct 1;279(40):41822-9
pubmed: 15286083
Nat Neurosci. 2019 Sep;22(9):1383-1388
pubmed: 31358992
RNA. 2014 Sep;20(9):1476-87
pubmed: 25051970
EMBO J. 1991 Mar;10(3):573-83
pubmed: 1825809
Dev Biol. 2007 Oct 1;310(1):99-112
pubmed: 17727835
Nucleic Acids Res. 2016 Sep 19;44(16):7884-95
pubmed: 27257078
Sci Rep. 2017 Sep 13;7(1):11490
pubmed: 28904332
Science. 1999 Feb 19;283(5405):1168-71
pubmed: 10024243
Trends Biochem Sci. 2015 Oct;40(10):560-575
pubmed: 26410597
Mol Cell. 2017 Jul 6;67(1):71-83.e7
pubmed: 28625553
Development. 1998 Jul;125(13):2403-14
pubmed: 9609823
Prog Nucleic Acid Res Mol Biol. 1990;39:241-303
pubmed: 2247610
Mol Cell. 2018 Aug 2;71(3):364-374
pubmed: 30075139
J Mol Biol. 1988 May 20;201(2):289-314
pubmed: 3418702
Cell. 1992 Sep 4;70(5):829-40
pubmed: 1339313